Cargando…
IP(3)R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP(3)R-derived peptide targeting the BH4 domain of Bcl-2
Disrupting inositol 1,4,5-trisphosphate (IP(3)) receptor (IP(3)R)/B-cell lymphoma 2 (Bcl-2) complexes using a cell-permeable peptide (stabilized TAT-fused IP(3)R-derived peptide (TAT-IDP(S))) that selectively targets the BH4 domain of Bcl-2 but not that of B-cell lymphoma 2-extra large (Bcl-Xl) pote...
Autores principales: | Akl, H, Monaco, G, La Rovere, R, Welkenhuyzen, K, Kiviluoto, S, Vervliet, T, Molgó, J, Distelhorst, C W, Missiaen, L, Mikoshiba, K, Parys, J B, De Smedt, H, Bultynck, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674349/ https://www.ncbi.nlm.nih.gov/pubmed/23681227 http://dx.doi.org/10.1038/cddis.2013.140 |
Ejemplares similares
-
Selective regulation of IP(3)-receptor-mediated Ca(2+) signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl
por: Monaco, G, et al.
Publicado: (2012) -
Bax Inhibitor-1 is a novel IP(3) receptor-interacting and -sensitizing protein
por: Kiviluoto, S, et al.
Publicado: (2012) -
Constitutive IP(3) signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP(3) receptor disruptor BIRD-2
por: Bittremieux, Mart, et al.
Publicado: (2018) -
Alpha-Helical Destabilization of the Bcl-2-BH4-Domain Peptide Abolishes Its Ability to Inhibit the IP(3) Receptor
por: Monaco, Giovanni, et al.
Publicado: (2013) -
IP(3) Receptors, Mitochondria, and Ca(2+) Signaling: Implications for Aging
por: Decuypere, Jean-Paul, et al.
Publicado: (2011)